TAAR1 and psychotic disorder: Although additional studies are necessary to further elucidate the potential interaction between TAAR1 and 5-HT1A in vitro and in vivo, compounds with dual TAAR1/5-HT1A activity may provide additional benefits in the treatment of psychosis, mood and anxiety.